Cigna Corporation (NYSE:CI) had its target price raised by equities researchers at Deutsche Bank AG from $180.00 to $190.00 in a note issued to investors on Monday. The firm presently has a “buy” rating on the health services provider’s stock. Deutsche Bank AG’s target price would indicate a potential upside of 7.97% from the stock’s current price.

Other analysts also recently issued reports about the stock. UBS AG restated a “buy” rating and set a $186.00 price target (up from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. ValuEngine upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Jefferies Group LLC boosted their price target on shares of Cigna Corporation from $178.00 to $183.00 and gave the company a “buy” rating in a report on Monday, May 15th. Stifel Nicolaus boosted their price target on shares of Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a report on Monday, May 15th. Finally, Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a report on Tuesday, April 25th. Two investment analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $179.89.

Cigna Corporation (NYSE CI) traded up 1.99% during trading on Monday, reaching $175.98. The company had a trading volume of 1,692,138 shares. The firm has a market capitalization of $45.05 billion, a P/E ratio of 23.50 and a beta of 0.46. The company has a 50-day moving average of $170.76 and a 200-day moving average of $157.68. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $176.98.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. Cigna Corporation had a return on equity of 17.58% and a net margin of 7.46%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.98 earnings per share. Analysts expect that Cigna Corporation will post $9.85 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/08/07/cigna-corporation-nyseci-pt-raised-to-190-00.html.

In related news, Director Jane E. Md Henney sold 600 shares of the stock in a transaction dated Monday, July 24th. The shares were sold at an average price of $174.14, for a total value of $104,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David Cordani sold 153,168 shares of the stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the transaction, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at approximately $71,681,772.40. The disclosure for this sale can be found here. Insiders have sold 219,558 shares of company stock valued at $37,135,665 in the last ninety days. 1.30% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. Waddell & Reed Financial Inc. boosted its stake in shares of Cigna Corporation by 125.8% in the first quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock valued at $256,306,000 after buying an additional 974,747 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares in the last quarter. Thrivent Financial For Lutherans boosted its stake in shares of Cigna Corporation by 7,868.4% in the first quarter. Thrivent Financial For Lutherans now owns 708,390 shares of the health services provider’s stock valued at $103,772,000 after buying an additional 699,500 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Cigna Corporation by 221.8% in the first quarter. AQR Capital Management LLC now owns 926,328 shares of the health services provider’s stock valued at $135,698,000 after buying an additional 638,426 shares in the last quarter. 86.91% of the stock is currently owned by hedge funds and other institutional investors.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.